A diterpenoid derivate compound targets selenocysteine of thioredoxin reductases and induces Bax/Bak-independent apoptosis.

[1]  M. Li,et al.  Enhancement of Auranofin-Induced Apoptosis in MCF-7 Human Breast Cells by Selenocystine, a Synergistic Inhibitor of Thioredoxin Reductase , 2013, PloS one.

[2]  E. Cadenas,et al.  Mitochondrial thiols in the regulation of cell death pathways. , 2012, Antioxidants & redox signaling.

[3]  N. Yoo,et al.  Rare somatic mutation of pro-apoptotic BAX and BAK genes in common human cancers. , 2012, Tumori.

[4]  M. Hogarty,et al.  Molecular and Cellular Pathobiology Mitochondrial Bcl-2 Family Dynamics Define Therapy Response and Resistance in Neuroblastoma , 2022 .

[5]  Yaxue Zhao,et al.  Adenanthin targets peroxiredoxin I and II to induce differentiation of leukemic cells. , 2012, Nature chemical biology.

[6]  D. Ross,et al.  Antitumor Indolequinones Induced Apoptosis in Human Pancreatic Cancer Cells via Inhibition of Thioredoxin Reductase and Activation of Redox Signaling , 2012, Molecular Pharmacology.

[7]  V. Gladyshev,et al.  HIF-Independent Regulation of Thioredoxin Reductase 1 Contributes to the High Levels of Reactive Oxygen Species Induced by Hypoxia , 2012, PloS one.

[8]  T. Seidal,et al.  The apoptosis regulators p53, bax and PUMA: Relationship and impact on outcome in early stage (FIGO I-II) ovarian carcinoma after post-surgical taxane-based treatment. , 2011, Oncology reports.

[9]  Biyun Ni,et al.  Natural Diterpenoid Compound Elevates Expression of Bim Protein, Which Interacts with Antiapoptotic Protein Bcl-2, Converting It to Proapoptotic Bax-like Molecule* , 2011, The Journal of Biological Chemistry.

[10]  Yong Liu,et al.  Phenylarsine Oxide Induces Apoptosis in Bax- and Bak-Deficient Cells through Upregulation of Bim , 2011, Clinical Cancer Research.

[11]  Hu Wei,et al.  Inhibition of thioredoxin reductase by auranofin induces apoptosis in adriamycin-resistant human K562 chronic myeloid leukemia cells. , 2011, Die Pharmazie.

[12]  X. Hao,et al.  A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/β-catenin signaling and colon cancer cell tumorigenesis , 2011, Cell Research.

[13]  B. Lefkove,et al.  Disruption of the mitochondrial thioredoxin system as a cell death mechanism of cationic triphenylmethanes. , 2011, Free radical biology & medicine.

[14]  Liu Jingjing,et al.  オーラノフィンによるチオレドキシン還元酵素の抑制は,アドリアマイシン抵抗性ヒトK562慢性骨髄性白血病細胞におけるアポトーシスを誘導する | 文献情報 | J-GLOBAL 科学技術総合リンクセンター , 2011 .

[15]  A. Fernandes,et al.  Selenium and the selenoprotein thioredoxin reductase in the prevention, treatment and diagnostics of cancer. , 2010, Antioxidants & redox signaling.

[16]  S. Chattopadhyay,et al.  Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR element , 2010, The EMBO journal.

[17]  V. Gladyshev,et al.  Characterization of protein targets of mammalian thioredoxin reductases. , 2010, Methods in enzymology.

[18]  G. Wondrak.  Redox-directed cancer therapeutics: molecular mechanisms and opportunities. , 2009, Antioxidants & redox signaling.

[19]  Raymond C Stevens,et al.  Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain. , 2009, Chemistry & biology.

[20]  K. Brown,et al.  The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation. , 2008, Biochemical pharmacology.

[21]  B. Rigas,et al.  The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents. , 2008, Cancer research.

[22]  P. Petit,et al.  Cysteine 62 of Bax Is Critical for Its Conformational Activation and Its Proapoptotic Activity in Response to H2O2-induced Apoptosis* , 2008, Journal of Biological Chemistry.

[23]  Elias S. J. Arnér,et al.  Cell Death by SecTRAPs: Thioredoxin Reductase as a Prooxidant Killer of Cells , 2008, PloS one.

[24]  B. Brüne,et al.  The mitochondrial thioredoxin system regulates nitric oxide-induced HIF-1alpha protein. , 2008, Free radical biology & medicine.

[25]  M. Capecchi,et al.  Effects of thioredoxin reductase-1 deletion on embryogenesis and transcriptome. , 2007, Free radical biology & medicine.

[26]  K. Fritz-Wolf,et al.  The structure of human thioredoxin reductase 1 provides insights into C-terminal rearrangements during catalysis. , 2007, Journal of molecular biology.

[27]  Young-sook Lee,et al.  Effect of thioredoxin reductase 1 on glucocorticoid receptor activity in human outer root sheath cells. , 2007, Biochemical and biophysical research communications.

[28]  H. Zeng,et al.  The mechanism of apoptosis induced by a novel thioredoxin reductase inhibitor in A549 cells: possible involvement of nuclear factor-kappaB-dependent pathway. , 2007, European journal of pharmacology.

[29]  P. Nguyen,et al.  Thioredoxin reductase as a novel molecular target for cancer therapy. , 2006, Cancer letters.

[30]  Jun Yan,et al.  A thioredoxin reductase inhibitor induces growth inhibition and apoptosis in five cultured human carcinoma cell lines. , 2006, Cancer letters.

[31]  Kikuya Kato,et al.  High Thioredoxin Expression Is Associated with Resistance to Docetaxel in Primary Breast Cancer , 2005, Clinical Cancer Research.

[32]  V. Gladyshev,et al.  Crystal structures of oxidized and reduced mitochondrial thioredoxin reductase provide molecular details of the reaction mechanism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Holmgren,et al.  Thioredoxin Reductase Is Irreversibly Modified by Curcumin , 2005, Journal of Biological Chemistry.

[34]  S. de Vos,et al.  FOXO‐dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  Gerhard K. H. Przemeck,et al.  Cytoplasmic Thioredoxin Reductase Is Essential for Embryogenesis but Dispensable for Cardiac Development , 2005, Molecular and Cellular Biology.

[36]  Richard A. Miller,et al.  The thioredoxin reductase/thioredoxin system: Novel redox targets for cancer therapy , 2005, Cancer biology & therapy.

[37]  W. Wurst,et al.  Essential Role for Mitochondrial Thioredoxin Reductase in Hematopoiesis, Heart Development, and Heart Function , 2004, Molecular and Cellular Biology.

[38]  K. Das.  Thioredoxin system in premature and newborn biology. , 2004, Antioxidants & redox signaling.

[39]  M. Mirault,et al.  Mitochondrial Thioredoxin System , 2004, Journal of Biological Chemistry.

[40]  R. Coombes,et al.  FoxO3a Transcriptional Regulation of Bim Controls Apoptosis in Paclitaxel-treated Breast Cancer Cell Lines* , 2003, Journal of Biological Chemistry.

[41]  P. Coffer,et al.  FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons , 2003, The Journal of cell biology.

[42]  D. Alberts,et al.  Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival. , 2003, The Journal of laboratory and clinical medicine.

[43]  R. Guigó,et al.  Characterization of Mammalian Selenoproteomes , 2003, Science.

[44]  K. Tonissen,et al.  The thioredoxin-thioredoxin reductase system: over-expression in human cancer. , 2003, Anticancer research.

[45]  B. Dörken,et al.  Combined p53/Bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instability , 2003, Cell Death and Differentiation.

[46]  G. Powis,et al.  Thioredoxin reductase and cancer cell growth inhibition by organotellurium antioxidants , 2003, Anti-cancer drugs.

[47]  P. Cassidy,et al.  Electrophilic Prostaglandins and Lipid Aldehydes Repress Redox-sensitive Transcription Factors p53 and Hypoxia-inducible Factor by Impairing the Selenoprotein Thioredoxin Reductase* , 2003, The Journal of Biological Chemistry.

[48]  J. Yodoi,et al.  Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation , 2002, Oncogene.

[49]  E. White,et al.  BAX and BAK mediate p53-independent suppression of tumorigenesis. , 2002, Cancer cell.

[50]  M. Ueno,et al.  Redox control of cell death. , 2002, Antioxidants & redox signaling.

[51]  Elias S. J. Arnér,et al.  Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. , 2001, Free radical biology & medicine.

[52]  V. Georgoulias,et al.  Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[53]  S. Reddy,et al.  Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination , 2001, Oncogene.

[54]  J. Lammers,et al.  Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1 , 2000, Current Biology.

[55]  A. Holmgren,et al.  Essential Role of Selenium in the Catalytic Activities of Mammalian Thioredoxin Reductase Revealed by Characterization of Recombinant Enzymes with Selenocysteine Mutations* , 2000, The Journal of Biological Chemistry.

[56]  T. Stadtman,et al.  Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[57]  J. Gierse,et al.  Kinetic basis for selective inhibition of cyclo-oxygenases. , 1999, The Biochemical journal.

[58]  J. Gustafsson,et al.  Human mitochondrial thioredoxin reductase cDNA cloning, expression and genomic organization. , 1999, European journal of biochemistry.

[59]  M. Greenberg,et al.  Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.

[60]  S. Rhee,et al.  Molecular Cloning and Characterization of a Mitochondrial Selenocysteine-containing Thioredoxin Reductase from Rat Liver* , 1999, The Journal of Biological Chemistry.

[61]  Kohei Miyazono,et al.  Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.

[62]  D. Kirkpatrick,et al.  Selenium and the thioredoxin redox system: effects on cell growth and death. , 1997, Oncology research.

[63]  S. Korsmeyer,et al.  Bax suppresses tumorigenesis and stimulates apoptosis in vivo , 1997, Nature.

[64]  Elias S. J. Arnér,et al.  Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase. , 1996, Biochemical and biophysical research communications.

[65]  John Calvin Reed,et al.  Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. , 1996, Oncogene.

[66]  A. Holmgren,et al.  1-Chloro-2,4-dinitrobenzene Is an Irreversible Inhibitor of Human Thioredoxin Reductase , 1995, The Journal of Biological Chemistry.

[67]  D. Smith,et al.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. , 1988, Gene.

[68]  A. Holmgren,et al.  Rat liver thioredoxin and thioredoxin reductase: purification and characterization. , 1982, Biochemistry.